C12Y 306/03008
Ca2+-transporting atpase
Official title: Ca2+-transporting ATPase (3.6.3.8)
C12Y306/03008 (Ca2+-transporting atpase) appears on 12 US grants and 22 published applications in this corpus.
Search patents in C12Y- Granted patents
- 12
- Published applications
- 22
- Assignees
- 22
- Inventors
- 50
- Latest grant
- 4 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 4 |
| 2018 | 0 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for prevention or treatment of heart failure4 Feb 2025US 12,215,362 B2Bethphagen Inc.
- Methods for efficient delivery of therapeutic molecules in vitro and in vivo1 Oct 2024US 12,102,691 B2Massachusetts Eye and Ear Infirmary
- Methods and compositions for consistent intracoronary administration of a biologic21 Feb 2023US 11,583,662 B2Sardocor Corp.
- Compositions and methods for treating and preventing pancreatitis, renal injury and cancer21 Sep 2021US 11,124,779 B2Yale University
- Method for efficient delivery of therapeutic molecules in vitro and in vivo27 Jul 2021US 11,071,790 B2Massachusetts Eye and Ear Infirmary
- Manipulating golgi ions for treatment of neurodegenerative disease and cutaneous disorders18 Jun 2026US 2026/0166178 A1Formation Venture Engineering Foundry, Inc.
- Methods and compositions for consistent intracoronary administration of a biologic25 Jan 2024US 2024/0024635 A1Sardocor Corp.
- Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis16 Mar 2023US 2023/0078498 A1University of Rochester
- Methods for efficient delivery of therapeutic molecules in vitro and in vivo21 Jul 2022US 2022/0226503 A1Massachusetts Eye and Ear Infirmary
- Pharmaceutical composition for prevention or treatment of heart failure30 Jul 2020US 2020/0239862 A1Bethphagen Inc.
Most cited
By later US patents
- Compositions and methods for modulating ATP2A2 expression9US 10,174,323 B2The General Hospital Corporation · 2019
- Methods of treating restenosis7US 7,291,604 B2The General Hospital Corporation · 2007
- Methods of treating disorders with glycosylation defective proteins3US 10,561,636 B2Case Western Reserve University · 2020
- Method for in vivo regulation of cardiac muscle contractility3US 7,745,416 B2The Regents of the University of California · 2010
- Efficient delivery of therapeutic molecules in vitro and in vivo2US 10,258,697 B2Massachusetts Eye and Ear Infirmary · 2019